Vivera Pharmaceuticals Welcomes His Excellency Salah Al Shamsi to Its Advisory Board

Newport Beach, California–(Newsfile Corp. – October 1, 2019) – Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management is pleased to announce the appointment of His Excellency Salah Salem Bin Omair Al Shamsi to the Company’s Advisory Board. A prominent business leader with unparalleled high level expertise, a large part of his role […]

Vivera Pharmaceuticals’ Advisory Board Member Ron Brown Speaks Out About National Concussion Awareness Day

Newport Beach, California–(Newsfile Corp. – September 19, 2019) – Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management announces its support of National Concussion Awareness Day®, an opportunity for organizations to join the conversation to increase concussion awareness nationally and support those who are suffering annually on September 20th. Ron Brown, an Advisory […]

Vivera Pharmaceuticals Supports Pain Awareness Month

Newport Beach, California–(Newsfile Corp. – September 12, 2019) – Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management announces its support of Pain Awareness Month, a time when various organizations work to raise public awareness about the issues in the area of pain and pain management annually in September. “Pain is an invisible […]

Vivera Pharmaceuticals Welcomes Tara Conner To Ambassador Board

Newport Beach, California–(Newsfile Corp. – September 5, 2019) – Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management is pleased to welcome Tara Conner to the Company’s Ambassador Board. A tireless recovery advocate, Ms. Conner will help raise awareness of Vivera’s non-addictive pain management solutions as an integral part of long-term recovery. “When […]

Vivera Pharmaceuticals’ Chief Medical Officer Dr. Stephen J. McColgan Appointed Clinical Instructor At University of California, Riverside, School of Medicine

Newport Beach, California–(Newsfile Corp. – August 14, 2019) – Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management is pleased to announce that its Chief Medical Officer, Dr. McColgan, has been appointed as Clinical Instructor at the University of California, Riverside (UCR), School of Medicine. The UCR School of Medicine is known for […]

Vivera Pharmaceuticals Welcomes Daniel Baldwin to Ambassador Board

Newport Beach, California–(Newsfile Corp. – August 8, 2019) – Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management is pleased to welcome Mr. Daniel Baldwin to the Company’s Ambassador Board. A long-time advocate for addiction recovery, Mr. Baldwin is helping to promote Vivera’s mission of developing non-addictive pain management solutions, including the TVIA […]

Vivera Pharmaceuticals Welcomes Sally Pera To Advisory Board

Newport Beach, California–(Newsfile Corp. – July 29, 2019) – Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management is pleased to announce the appointment of Sally Pera to the Company’s Advisory Board. A thought leader and corporate strategy expert, Ms. Pera will be instrumental in building integral relationships to further Vivera’s mission of […]

Vivera Pharmaceuticals Names Brad Townend Executive Creative Director

Newport Beach, California–(Newsfile Corp. – July 25, 2019) – Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces the appointment of Brad Townend to Executive Creative Director. In this role, Mr. Townend will be responsible for creating and overseeing the Vivera brand in every aspect from the Company’s digital presence to […]

Vivera Pharmaceuticals Committed To Research and Development To Help Fight The Opioid Crisis

Newport Beach, California–(Newsfile Corp. – July 18, 2019) – Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announces its continued commitment to the advancement of research and development of cannabidiol (CBD)-based therapies as effective alternatives to opioids in response to newly released federal data regarding the opioid crisis. “Vivera is taking […]